Bagattini Ângela Maria, da Rosa Michelle Quarti Machado, Gomez Jorge A, Ballivian Jamile, Casarini Agustín, Bardach Ariel, Toscano Cristiana Maria
Universidade Federal de Goiás, Instituto de Patologia Tropical e Saúde Pública, Goiânia, GO, Brazil.
Universidade Federal de Goiás, Instituto de Patologia Tropical e Saúde Pública, Goiânia, GO, Brazil.
Braz J Infect Dis. 2025 Jul 4;29(5):104560. doi: 10.1016/j.bjid.2025.104560.
Herpes Zoster (HZ) and its complications, such as Postherpetic Neuralgia (PHN), are associated with significant burden in elderly. In Brazil, data on economic and epidemiologic HZ burden is still limited. We conducted a Delphi panel to assess healthcare resource use in HZ outpatients aged 50-years and older. Diagnosis and treatment resources, proportion of referral and hospitalization were estimated considering HZ, PHN, ophthalmic and neurologic zoster typical cases. A diverse group of 20 medical specialists was selected, and responded anonymously to an online questionnaire. Consensus was met if ≥ 75 % agreement was reached in the 1st round, and if not met, a 2nd round was held. Summary statistics are reported stratified by age-groups and healthcare system (public and private). Responses were obtained from 19 and 17 panel members in the 1st and 2nd rounds, respectively. The proportion HZ outpatients with PHN increased significantly with age (4 % in 50‒59; 14 % in ≥ 80 years). Ophtalmic and neurological complications ranged from 5 %‒13 % across age groups. Absenteeism was high, ranging from 30 %‒68 % of patients depending on the clinical presentation. HZ patients required 2‒3 medical visits, and referral to another medical specialty varied from 10 %‒22 % across age ranges, doubling for NPH patients. Proportion of hospitalization varied from 1-8 %. HZ diagnosis was mainly clinical (93 %). Acyclovir (95 %) and valaciclovir (80 %) were the therapy of choice in the public and private systems, respectively. Pain management included dipyrone and codeine (63 %), pregabalin (58 %), and gabapentin (Neurontin) (48 %). Our results report significant healthcare resource utilization by elderly HZ patients in Brazil.
带状疱疹(HZ)及其并发症,如带状疱疹后神经痛(PHN),给老年人带来了沉重负担。在巴西,关于HZ经济和流行病学负担的数据仍然有限。我们开展了一项德尔菲专家小组研究,以评估50岁及以上HZ门诊患者的医疗资源使用情况。考虑到HZ、PHN、眼部和神经型带状疱疹的典型病例,对诊断和治疗资源、转诊和住院比例进行了估算。挑选了20名不同的医学专家组成小组,他们对一份在线问卷进行匿名回复。如果第一轮达成≥75%的共识,则达成一致意见;如果未达成,则进行第二轮调查。汇总统计数据按年龄组和医疗系统(公立和私立)分层报告。第一轮和第二轮分别收到了19名和17名小组成员的回复。患有PHN的HZ门诊患者比例随年龄显著增加(50 - 59岁为4%;80岁及以上为14%)。各年龄组的眼部和神经并发症发生率在5% - 13%之间。缺勤率很高,根据临床表现,患者缺勤率在30% - 68%之间。HZ患者需要就诊2 - 3次,转诊至其他医学专科的比例在各年龄组中为10% - 22%,NPH患者的这一比例翻倍。住院比例在1% - 8%之间。HZ诊断主要依靠临床诊断(93%)。在公立和私立医疗系统中,阿昔洛韦(95%)和伐昔洛韦(80%)分别是首选治疗药物。疼痛管理包括使用安乃近和可待因(63%)、普瑞巴林(58%)以及加巴喷丁(48%)。我们的研究结果显示,巴西老年HZ患者的医疗资源利用率很高。